The estimated Net Worth of Anna Lucsok is at least $622 Thousand dollars as of 6 August 2024. Ms Lucsok owns over 24,875 units of Zynex Inc stock worth over $135,161 and over the last 4 years she sold ZYXI stock worth over $315,837. In addition, she makes $170,891 as Chief Operating Officer at Zynex Inc.
Ms has made over 3 trades of the Zynex Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently she sold 24,875 units of ZYXI stock worth $199,498 on 6 August 2024.
The largest trade she's ever made was selling 24,875 units of Zynex Inc stock on 6 August 2024 worth over $199,498. On average, Ms trades about 949 units every 15 days since 2021. As of 6 August 2024 she still owns at least 16,980 units of Zynex Inc stock.
You can see the complete history of Ms Lucsok stock trades at the bottom of the page.
Anna Lucsok is the Chief Operating Officer at Zynex Inc.
As the Chief Operating Officer of Zynex Inc, the total compensation of Ms Lucsok at Zynex Inc is $170,891. There are 5 executives at Zynex Inc getting paid more, with Giuseppe Papandrea having the highest compensation of $1,901,890.
Ms Lucsok is 35, she's been the Chief Operating Officer of Zynex Inc since . There are 8 older and no younger executives at Zynex Inc. The oldest executive at Zynex Inc is Barry Michaels, 70, who is the Independent Director.
Anna's mailing address filed with the SEC is 9655 MAROON CIRCLE, , ENGLEWOOD, CO, 80112.
Over the last 6 years, insiders at Zynex Inc have traded over $45,302,249 worth of Zynex Inc stock and bought 14,733 units worth $121,235 . The most active insiders traders include Thomas Sandgaard Holdings L..., Joshua R. Disbrow, and Thomas Sandgaard. On average, Zynex Inc executives and independent directors trade stock every 56 days with the average trade being worth of $657,783. The most recent stock trade was executed by Anna Lucsok on 6 August 2024, trading 24,875 units of ZYXI stock currently worth $199,498.
zynex, inc. founded in 1996, engineers, manufactures and markets neuro-diagnostics, stroke rehabilitation, pain management and cardiac monitoring devices within three subsidiaries. zynex medical is a provider of electrotherapy products for home use. zynex monitoring solutions develops products for cardiac monitoring for use in hospitals. zynex neurodiagnostics develops devices for emg and eeg diagnostic applications within neurology disciplines. zynex medical's product line is fully developed, fda/ce cleared, commercially sold, and has been developed to uphold the company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. zynex monitoring solutions and zynex neurodiagnostics are currently both in the development stages without any significant revenues.
Zynex Inc executives and other stock owners filed with the SEC include: